Summary
The ACTION score for pediatric VAD candidates was developed to predict mortality after device placement, but had been tested only within the dataset used to build it.
Researchers validated the score against an outside source, the publicly available Pedimacs dataset of 531 patients. They then compared the ACTION score with the INTERMACS profile, a widely used measure of how ill a patient is before device placement, using both the Pedimacs data and a contemporary ACTION dataset of 1,304 patients.
In the Pedimacs data, the proportion of deaths rose steadily as ACTION scores increased. The score’s ability to distinguish patients who died from those who did not, measured by area under the curve, was 0.71 — what the authors describe as a fair predictor. In the ACTION dataset, both measures showed the same upward trend, but the ACTION score again reached 0.71 while the INTERMACS profile reached 0.58.
The authors conclude that the ACTION score is externally validated and predicted mortality better than the INTERMACS profile in both the historical and contemporary datasets.
This ACTION study was published online ahead of print in ASAIO Journal on November 9, 2026. Congratulations to the authors:
- Meaghan Reaney
- Katerina Boucek
- Angela Lorts
- David N. Rosenthal
- Ke Yan
- Jian Zhang
- Robert Aaron Niebler
CITATION
Reaney M, Boucek K, Lorts A, et al. External validation of a risk score assessment for pediatric ventricular assist device mortality. ASAIO J. Published online November 9, 2026. doi:10.1097/MAT.0000000000002898
